Creative Planning
ALT icon

Creative Planning’s Altimmune ALT Stock Holding History

Creative Planning’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,000
Closed -$4.51K – 3194
2024
Q2 		$4.51K Hold
3,000
– – ﹤0.01% 3030
2024
Q1 		$13.2K Buy
+3,000
New +$30.5K ﹤0.01% 2858

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Creative Planning's ALT Position: Q1 2026 in Review

Creative Planning reduced its Altimmune (ALT) stake by 16% in Q1 2026, selling an estimated $32.5K and leaving 39,229 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #3859.

Creative Planning first reported a position in ALT in Q1 2014 and has held it in 21 quarters since. The position peaked at $342K in Q3 2020. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Creative Planning held 39,229 shares of Altimmune worth $121K as of Q1 2026.
  • Creative Planning sold 7,657 Altimmune shares in Q1 2026, an estimated $32.5K.
  • Altimmune made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #3859 holding.
  • Creative Planning first reported a position in Altimmune in Q1 2014 and has held it in 21 quarters since.
  • Creative Planning's Altimmune position peaked at $342K in Q3 2020.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.